Region Midtjylland — Sponsor Intelligence | 59 EU Trials

Filter these 59 trials by condition, phase, country and more.

Open in Search →

59 Registered trials

36 Recruiting

14 Completed trials

4 Countries active

90 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I/II

Phase III/IV

Phase IV

Phase III: 11 Phase II/III: 1 Phase II: 8 Phase I/II: 6 Phase III/IV: 7 Phase IV: 21 Phase I: 2 Phase I (Other): 2 Phase I (FiH): 1

Oversight events:

1 serious breach 1 temporary halt across 2 trials

View oversight register →

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Chronic hepatitis B 2 Turner's syndrome 2 Obesity 1 Implant site infection 1 Non-alcoholic steatohepatitis 1 Glioblastoma multiforme 1 Glioblastoma 1 Malignant glioma 1 Tubulointerstitial nephritis 1 Chronic kidney disease 1 Low anterior resection syndrome 1

Top IMPs

ESTRADIOL 5 SODIUM CHLORIDE 3 FUROSEMIDE 2 IBUPROFEN 2 LIDOCAINE HYDROCHLORIDE 2 PARACETAMOL 2 POMALIDOMIDE 2 PROGESTERONE PH. EUR. 2 SEMAGLUTIDE 2 TAMSULOSIN HYDROCHLORIDE 2 VENETOCLAX 2 ALFACALCIDOL 1

All trials — page 3

59 total

MASTER Ended

2024-515404-39-00 Phase III 1 country ATORVASTATIN
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLA Ended

2024-510865-41-00 Phase IV 1 country
DAHANCA 30: A randomized non-inferiority trial of hypoxia-profile guided hypoxic modification with nimorazole during radiotherapy/chemoradio… Ended

2024-516178-31-00 Phase III 2 countries NIMORAZOLE
RGX Ended

2024-514903-33-00 Phase II 1 country DENOSUMAB; ZOLEDRONIC ACID MONOHYDRATE
What are the effects of using 10 versus 20 ml of local anesthetic for Plexus Popliteal Block on opioid consumption, pain, and patient-report… Ended

2024-520204-26-00 Phase IV 1 country
Duration of peripheral nerve blocks in opioid tolerant individuals Ended

2023-509351-13-00 Phase IV 1 country LIDOCAINE HYDROCHLORIDE
Effects of extensive Weight loss on Insulin resistance and Lipid-kinetics in people with obesity and fatty liver Disease Ended

2023-506300-12-00 Phase IV 1 country SEMAGLUTIDE
The effect of the Popliteal Plexus Block on muscle function of the leg - a scientific trial in healthy volunteers Ended

2023-505263-37-00 Phase III/IV 1 country LIDOCAINE HYDROCHLORIDE; PROPOFOL
Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis Ended

2024-518643-38-00 Phase I/II 1 country ALLOGENEIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS EXPANDED; SODIUM CHLORI…
Treatment of bowel dysfunction after surgery for rectal cancer using transanal irrigation or laxatives Ended

2024-519492-25-01 Phase III/IV 1 country GLYCEROL
Subcutaneous Immunoglobulin in De-novo CIDP - SIDEC Ended

2024-515898-96-01 Phase III/IV 1 country HUMAN NORMAL IMMUNOGLOBULIN

Showing 49–59 of 59 trials

← All sponsors A–Z